Bedaquiline in multidrug-resistant tuberculosis treatment: Safety and efficacy in a Korean subpopulation
{{output}}
Background: The final treatment outcomes of Korean multidrug-resistant tuberculosis (MDR-TB) patients treated with bedaquiline in the C209 trial have not yet been reported. Therefore, a subgroup analysis of the Korean population ... ...
